Aroneb 15 mcg/2 ml is a Product of the Generic Arformoterol Tartrate

Aroneb 15 mcg/2 ml belongs to the generic category of Arformoterol Tartrate. This medicine should be used according to a doctor's advice. We have provided detailed information about the uses, dosage, effectiveness, side effects, precautions, drug interactions, storage conditions, and other important details of Aroneb 15 mcg/2 ml. Our goal is to present essential medicine information in one place for patients, caregivers, and healthcare professionals. To better understand Arformoterol Tartrate and ensure the safe use of this medicine, please read the information below carefully and consult a healthcare professional when necessary.

Description of Aroneb 15 mcg/2 ml

Aroneb 15 mcg/2 ml may be available as a prescription or over-the-counter medicine, depending on local regulations and medical recommendations. It is used for the treatment and management of specific conditions or symptoms. The way this medicine is used may vary depending on the patient's condition and the advice of a healthcare provider. Detailed information about the approved uses, therapeutic applications, and other relevant details of Aroneb 15 mcg/2 ml is provided below to help users gain a clear understanding of this medicine.

What Is Aroneb 15 mcg/2 ml Indications and Uses?

Aroneb 15 mcg/2 ml (Arformoterol Tartrate) is indicated for long-term, twice daily (morning and evening) administration in the maintenance treatment of broncho-constriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. Important limitations of use: Aroneb ... Read more Aroneb 15 mcg/2 ml (Arformoterol Tartrate) is indicated for long-term, twice daily (morning and evening) administration in the maintenance treatment of broncho-constriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. Important limitations of use: Aroneb nebuliser solution is not indicated to treat acute deteriorations of COPD. People with asthma, who take long-acting beta 2 adrenergic agonist (LABA) medicines, such as Aroneb, have an increased risk of death from asthma problems

Dosage And Administration of Aroneb 15 mcg/2 ml

The recommended dose of Aroneb 15 mcg/2 ml (Arformoterol Tartrate) nebuliser solution is one 15 mcg unit-dose ampoule administered twice daily (morning and evening) by nebulization. A total daily dose of greater than 30 mcg (15 mcg twice daily) is not recommended. Pediatric Use: COPD does not occur in children. The safety and efficacy of Arformoterol nebuliser solution in pediatric patients have not been established

Drug Interactions of Aroneb 15 mcg/2 ml

Other adrenergic drugs may potentiate effect. Xanthine derivatives, steroids, diuretics, or non-potassium sparing diuretics may potentiate hypokalemia or ECG changes. MAO inhibitors, tricyclic antidepressants and drugs that prolong the QTc interval may potentiate effect on the cardiovascular system. Beta-blockers may decrease effectiveness.

Side Effects of Aroneb 15 mcg/2 ml

Most common adverse reactions are pain, chest pain, back pain, diarrhea, sinusitis, leg cramps, dyspnea, rash, flu syndrome, peripheral edema and lung disorder. Aroneb 15 mcg/2 ml (Arformoterol Tartrate) can cause serious side effects, including: People with asthma, who take LABA medicines, have an increased risk of death from asthma problems. Patient should get emergency medical care if: Breathing problems worsen quickly After the use of rescue inhaler medicine, it does not relieve breathing problems.

Precautions And Warnings for Aroneb 15 mcg/2 ml

Aroneb 15 mcg/2 ml (Arformoterol Tartrate) nebuliser should not be initiated in acutely deteriorating patients. It should be used with caution in patients with cardiovascular or convulsive disorders, thyrotoxicosis, or with sensitivity to sympathomimetic drugs. Life-threatening paradoxical bronchospasm can occur.

Use During Pregnancy and Lactation

Pregnancy Category C. Aroneb 15 mcg/2 ml (Arformoterol Tartrate) nebuliser solution should be used during pregnancy, only if the potential benefit justifies the potential risk to the fetus. It is not known whether arformoterol is excreted in human milk.

Therapeutic Class

Bronchodilator

Storage Conditions of It

Aroneb nebuliser solution should be stored at 2-8°C, protected from light and excessive heat. Do not freeze. Keep out of the reach of children. Pack Images: Aroneb 15 mcg Nebuliser Solution Thanks for using MedEx! How would you rate your experience so far?